Multisystem Inflammatory Syndrome in Children

Area of Science:

• Pediatric infectious diseases
• Immunology
• Cardiology

Background:

• Multisystem inflammatory disease in children (MIS-C) is a rare but serious condition following SARS-CoV-2 infection.
• It is characterized by a hyperinflammatory state affecting multiple organ systems.
• MIS-C typically occurs 3-6 weeks after an asymptomatic or mild COVID-19 infection.

Purpose of the Study:

• To summarize the clinical presentation, diagnostic criteria, and key evaluations for MIS-C.
• To highlight the importance of early recognition and management of this post-infectious sequela.

Main Methods:

• Review of clinical manifestations including fever, organ system dysfunction, and common symptoms like skin/mucosal, GI, and neurological involvement.
• Diagnostic criteria include vital sign instability, elevated inflammatory and cardiac markers, and confirmed SARS-CoV-2 exposure or infection.
• Echocardiography is essential for assessing cardiac involvement, such as coronary artery abnormalities and ventricular dysfunction.

Main Results:

• MIS-C presents with persistent fever and dysfunction in at least two organ systems.
• Diagnosis is one of exclusion, requiring differentiation from other infectious and non-infectious conditions.
• Cardiac dysfunction is a significant concern, necessitating echocardiographic evaluation.

Conclusions:

• MIS-C is a distinct post-infectious syndrome requiring prompt diagnosis and management.
• Multidisciplinary care involving infectious disease specialists, immunologists, and cardiologists is crucial.
• Early identification and treatment can mitigate severe complications, particularly cardiac sequelae.